How Sentry is helping covered entities contend with contract pharmacy exclusions

With more and more drug manufacturers excluding their products from 340B contract pharmacies, covered entities are asking two questions: When does this end? And what should we do about it? At Sentry, we’re asking ourselves, how can we best support our customers in these challenging circumstances?

With drugs like AbbVie’s best-selling Humira, Merck’s Keytruda and diabetic drugs from five different manufacturers, it’s safe to say that the contract pharmacy exclusions are taking an ever-increasing bite out of covered entities’ 340B benefits and curtailing their ability to provide critical safety-net services in their communities. We know this from speaking with thousands of covered entity end-users, stakeholders, and advocates. One customer of ours, a large urban health system, has lost over $70 million in program benefits to date from Sanofi alone. The impact is real and has lasting effects on caring for the most vulnerable.

Read the full report here.

Sentry’s Head of Industry Relations authors new 340B compliance whitepaper

Lisa Scholz, PharmD, MBA, FACHE, has authored a new whitepaper for the Texas Healthcare Trustees outlining the three key compliance factors 340B covered entities must contend with and discussing the unique operational challenges they pose for modern hospitals.

Titled “Key compliance factors of the 340B program and the challenges they pose for hospitals,” the whitepaper details the three basic pillars of 340B compliance:

  • 11-digit National Drug Code (NDC) matching
  • Policies & Procedures
  • Reporting

Scholz outlines the challenges 340B compliance presents for modern hospital information systems, workflows and operations. She also offers key questions to ask and best practices to covered entities that need help strengthening their compliance oversight or hospitals that are considering participating in 340B.

Fill out the form below to download the full whitepaper.

Modern Healthcare interviews Sentry’s Head of Industry Relations

Modern Healthcare spoke with Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, for a recent article, “Drugmakers crackdown on 340B discounts, demand data.”

The article covers the several manufacturer notices and letters to hospitals that pharma companies such as Eli Lilly, Merck and Sanofi have been sending to covered entity hospitals in an effort to limit or undermine the 340B drug discount program.

“These changes are aimed at the contract pharmacy model, and they are aimed at covered entities’ bottom lines. Through those pharmacies, covered entities are able to utilize those savings, and they use the benefits they receive to benefit their patient populations,” Scholz said in the article.

Click here to read more from Scholz on pharma’s recent push against 340B.

Sentry’s Head of Industry Relations published in Pharmacy Times

Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, has written a two-part article for Pharmacy Times about transparency in the 340B program. This second part, which has been published in the March issue, discusses the call for greater program transparency and why it’s important that transparency goes both ways.

Lisa has been an expert on the 340B program throughout her career, having previously served as both the vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as the chief operating officer and senior vice president at 340B Health.

Read the article

Sentry’s Head of Industry Relations published via Texas Healthcare Trustees

Lisa Scholz, PharmD., Sentry’s Head of Industry Relations, has published a white paper as part of the Texas Healthcare Trustees’  Governance Thought Leadership Series. The paper, “340B Program Transparency – is it ‘Trans-fair-ency’?” discusses the political, economic, social and technological factors that play into 340B program compliance and optimization, and the role that transparency plays.

Lisa has been an expert on the 340B program throughout her career, having previously served as both the vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as the chief operating officer and senior vice president at 340B Health.

Sentry’s Head of Industry Relations delivers expert 340B insights to healthcare executives

Lisa Scholz, Head of Industry Relations at Sentry Data Systems, recently participated in an online webinar series for the Texas Healthcare Trustees. The presentations,  “340B – Understanding the Basics” and “Strategic 340B Insights for Hospital Leaders,” aim to provide hospital leaders an overview of 340B and illustrate how they can play a critical role in shaping program utilization while outlining market opportunities, threats, and best practices.

Texas Healthcare Trustees is offering these presentations for general purchase as part of their online learning library. Lisa’s deep expertise as a pharmacist with 20+ years in the industry — both the public and private sector — make them a valuable asset for any healthcare leader involved in 340B program management and compliance.

Learn more

Sentry’s Chief Medical Officer published in Pharmaceutical Executive

William Kirsh, DO, MPH, Chief Medical Officer of Sentry Data Systems, has published an article in Pharmaceutical Executive magazine. The article, “A Broken System – Making Drug Decisions without Real-World Data,” discusses how using real-world data and real-world evidence to make formulary drug decisions can benefit both patients and health systems.

Dr. Kirsh is a published author and clinically certified in family practice, geriatrics, hospice and palliative medicine. As Chief Medical Officer and a founding partner of Sentry, Dr. Kirsh has been actively involved in the development, construction and deployment of Sentry’s applications.

Read the article

Sentry Data Systems and Oracle featured in Forbes

A recent article in Forbes magazine highlights Sentry’s analytics technology and the company’s recent partnership with Oracle for expanded data storage and security. Oracle’s Exadata Cloud at Customer service allows Sentry to keep its data behind its firewall while Oracle delivers and manages the data.

The article features quotes from key Sentry leaders, including founder and CEO Travis Leonardi, co-founder and Chief Medical Officer William Kirsh, DO, MPH, Chief Information Officer Kim Jacques, and Chief Revenue Officer William Sander.

Read the article: Data analytics platform helps hospitals reduce cost of patient care

Sentry’s Head of Industry Relations talks 340B with Specialty Pharmacy Times

Lisa Scholz, Sentry’s Head of Industry Relations, has published an article in Specialty Pharmacy Times. The article discusses the effect that the January CMS 340B reimbursement cuts have had on safety-net hospitals and offers suggestions for how hospital pharmacies can maximize revenue in the face of the 340B cuts.

Lisa has been an expert on the 340B program throughout her career, having previously served as both vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as chief operating officer and senior vice president at 340B Health.

Read the article: The Brave New World of 340B: Where do we go From Here?

Health Data Management publishes article from Sentry’s Chief Information Security Officer

John Ceraolo, Sentry’s Chief Information Security Officer, recently published an article in Health Data Management. The article discusses the need for hospitals’ security teams to engage all staff members in active data security practices in order to mitigate the risk of a security breach.

John focuses his expertise on the day-to-day execution of Sentry’s information security processes and ensures ongoing adoption of security and compliance best practices. He has more than 20 years of experience in the information security industry.

How to engage everyone to stop security gaffes in your organization

HIMSS publishes blog from Sentry CMO for NHIT Week

As we celebrate National HIT Week, HIMSS has published a blog post from William Kirsh, DO, MPH. The post discusses fighting the opioid epidemic while helping to solve the pain epidemic in the US, through the use of longitudinal data and data analytics.

As Chief Medical Officer and a founding partner of Sentry, Dr. Kirsh has been actively involved in the development, construction and deployment of Sentry’s applications.

An interwoven problem: the pain and opioid crises

Sentry’s Chief Medical Officer published in FierceHealthcare

William Kirsh, DO, MPH, Chief Medical Officer at Sentry, has recently had an article published in FierceHealthcare. The article discusses the ways in which longitudinal data and healthcare data analytics can help fight the opioid crisis while still treating pain.

Dr. Kirsh is a published author and clinically certified in family practice, geriatrics, hospice and palliative medicine. As Chief Medical Officer and a founding partner of Sentry, Dr. Kirsh has been actively involved in the development, construction and deployment of Sentry’s applications.

Industry Voices—5 ways longitudinal data can help fight the opioid crisis while still treating pain

Sentry’s VP of Analytics Services published in Healthcare Business Today

Brian Wedderspoon, Sentry’s Vice President of Analytics Services, has recently had an article published in Healthcare Business Today. The article discusses how software solutions for service line analytics calculate the costs and revenues for every individual patient and summarize that data, giving executives and managers the financial insights they need.

Brian has experience in financial management, strategic planning and performance improvement projects across the provider side of the healthcare landscape. He has an MBA in finance and strategy from the Georgetown University McDonough School of Business.

Why Every Hospital Needs Service Line Analytics

Pharmacy Practice News interviews Sentry’s head of industry relations

Lisa Scholz, Sentry’s Head of Industry Relations, has been quoted in a recent article published in Pharmacy Practice News. The article discusses the impact that the January 1 reimbursement cuts to the 340B program have had on safety net hospitals and provides an update on current House and Senate bills relating to the 340B program that are under consideration.

Lisa has been an expert on the 340B program throughout her career, having previously served as both vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as chief operating officer and senior vice president at 340B Health.

Read the article: As Losses Mount From 340B Cuts, Hospitals Cry Foul

Sentry named one of “30 admired companies to watch” in CIO Bulletin

In the June issue of CIO Bulletin, Sentry Founder and CEO Travis Leonardi, RPh, CP, discusses the vision behind the founding of Sentry Data Systems, the importance of offering customers ROI from both data software solutions and the longitudinal patient database, and Sentry’s continued focus on innovation. Sentry has also been named one of CIO Bulletin’s “2018 30 Admired Companies to watch.”

Travis has more than 30 years of experience in healthcare. A serial entrepreneur and pharmacist, he has founded several companies, all within the healthcare industry. He is a graduate of St. John’s Pharmacy School in New York.

Read the article: The Road to Actionable Analytics in Healthcare

HFMA publishes article from Sentry’s CMO

HFMA has published a new article from Sentry’s Chief Medical Officer, William Kirsh, DO, MPH. The article discusses the factors necessary for maintaining pharmacy revenue integrity and avoiding revenue leakage. It notes that if physicians and hospital executives are willing to acknowledge the powerful role data can play, the impact on both patient outcomes and revenue integrity can be tremendous.

As Chief Medical Officer and a founding partner of Sentry, Dr. Kirsh has been actively involved in the development, construction and deployment of Sentry’s applications.

Top Five Factors for Pharmacy Revenue Integrity

Sentry customer discusses analytics in Healthcare IT News interview

Healthcare IT News has published an interview with Dana Darger, Director of Pharmacy at Rapid City Regional Health (a Sentry customer). The article discusses the importance of looking at the big picture when it comes to data analytics for cost savings and revenue management.

Regional Health is comprised of five hospitals, which, combined, work with 25 contract pharmacies. The health system has been using Sentry’s Sentinel and Sentrex products for several years, and most recently signed on to use Sentry’s Senturion Analytics services. Dana will be speaking at the upcoming HIMSS Big Data & Healthcare Analytics forum on June 13 in San Francisco.

Read the article: Why hospitals need to adopt a ‘retail mindset’ when it comes to analytics

Sentry’s EVP of Sales and Marketing published in Specialty Pharmacy Times

Specialty Pharmacy Times has published a new article from Michael Sovie, Sentry’s EVP of Sales and Marketing. The article discusses how to mitigate the risk of drug diversion in hospitals, including how specialty drugs, in addition to narcotics, should be carefully monitored. The article highlights the value in analytics for addressing this growing issue.

Michael has been with Sentry Data Systems since 2008. He has a unique background with experience in business, healthcare sales and pharmacy leadership. Michael holds a PharmD and an MBA from Wilkes University in Pennsylvania.

Mitigating Drug Diversion Risk

Healthcare Business Today publishes article from Sentry’s VP of Analytics Services

Brian Wedderspoon, Sentry’s VP of Analytics Services, has published an article in Healthcare Business Today on the value of professional services in hospital analytics. The article discusses the evolution of data management in hospitals and health systems, from data collection to data analytics to being able to derive actionable information and insights from the data.

Brian has experience in financial management, strategic planning, and performance improvement projects across the provider side of the healthcare landscape. He has an MBA in Finance & Strategy from The Georgetown University McDonough School of Business.

The Evolutionary Development of Hospital Data Analytics

Sentry Chief Medical Officer featured in Becker’s Hospital Review

Sentry Data Systems is proud to share a new Becker’s Hospital Review article authored by William D. Kirsh, DO, MPH, Sentry’s Chief Medical Officer and one of our most highly regarded thought leaders. In the article, Dr. Kirsh offers his perspective on how the opioid epidemic in the US can be fought by using real-time, longitudinal data to look at the larger picture and help clinicians define, across an entire continuum of care, what combinations of medications are leading to the best patient outcomes.

Dr. Kirsh is clinically certified in Family Practice, Geriatrics, Hospice and Palliative Medicine and has been practicing medicine for over 25 years. He is a founding partner of Sentry.

The future of the fight against the opioid epidemic

Henry Ford Health System publishes open letter about effect of 340B reimbursement cuts

Sentry client Henry Ford Health System has published an open letter in Specialty Pharmacy Times detailing the devastating effects the recent 340B reimbursement cuts will have on the patients with the most need. Sentry stands with Henry Ford and other hospitals across the nation in voicing our continued support for the 340B program and the patients for which the program helps to provide essential care.

Scholz contributes to recent Pharmacy Today article focused on federal 340B cuts

Sentry’s senior vice president and chief customer engagement officer, Lisa Scholz, PharmD, MBA, has been quoted as a 340B expert in a recent article in Pharmacy Today, an official publication of the American Pharmacists Association. Lisa spoke to the publication about the need for hospitals to apply modifiers under the new CMS rule and 340B’s purpose of helping hospitals stretch scarce resources.

Sentry SVPs co-author HFMA article: 6 tips for rural hospital 340B drug pricing participation

In a recent article published by HFMA, Sentry’s Lidia Rodriguez-Hupp, SVP, Chief of Corporate Initiatives and 340B Compliance Officer, and Lisa Scholz, SVP and Chief Customer Engagement Officer, outline proactive steps that rural hospital and health system leaders can take to understand recent changes, stay focused on 340B program compliance, and get the most out of their 340B plan participation.

6 tips for rural hospital 340B drug pricing participation

Sentry thought leaders featured in new Specialty Pharmacy Times article

In a recent article published in Specialty Pharmacy Times, Sentry’s own Chief Medical Officer, William D. Kirsh, DO, MPH, and Chief Pharmacy Officer, Dawn DeAngelo, PharmD, weigh in on the reality of value-based care and the benefits of using a longitudinal patient data set that allows all stakeholders to analyze information in a way that is both meaningful and actionable.

Value-Based Care Is Becoming Real: Are You Prepared?

Sentry authors second article in three-part HIT Leaders and News series

As patient-centered care has made its way to center stage in our increasingly value-based healthcare system, clinicians must now consider a patient’s overall holistic care, including length of stay and drug regimens, in order to more fully understand trends and make more informed decisions.

While claims-based analytics offerings are often dated and incomplete, Sentry’s DataNext® pharmacy-based analytics solution allows medical management, finance and quality teams the transparency needed to view the patient from a completely different perspective. And this new analytics approach has shown the power to transform how health systems care for patients by unlocking insights not found anywhere else.

Read more about the next generation of pharmacy-based analytics in a recent HIT Leaders & News article from Dawn DeAngelo, Chief Pharmacy Officer at Sentry. It’s the second in a three-part series on the latest healthcare IT trends that Sentry is producing with HIT Leaders & News.

Could pharmacy-based analytics finally address the paradox of reducing costs while improving quality?

Sentry kicks off three-part article series for HIT Leaders & News

Payment reform, along with rising drug and medical device prices, are putting an incredible amount of pressure on hospitals’ bottom lines. As healthcare executives across the country look for ways to control costs while simultaneously bending the quality curve up, the ability to leverage accurate and timely data has become more important than ever.

Read more about our insights on the next generation of pharmacy and supply chain analytics in a recent HIT Leaders & News article authored by Tim Lantz, Senior Vice President, GM, Sentry Analytics & Product Design. It’s the first in a three-part series on the latest healthcare IT trends that Sentry is producing with HIT Leaders & News.

Pharmacy and supply chain analytics: Fast forward to the next generation (article no longer available)

Sentry SVP Tim Lantz offers perspective on data science for clinical decision support

In an article published in this month’s Healthcare Purchasing News, Sentry’s own Tim Lantz, Senior Vice President, GM, Sentry Analytics & Product Design, weighs in on the conversation about how supply chain professionals can partner with physicians to meet their shared goal of best possible outcomes for their respective areas of focus.

Motivating supply chain to embrace data science for clinical decision support (article no longer available)

Sentry’s principal analytics thought leader featured in Healthcare Purchasing News

Sentry Data Systems, Inc. is proud to share an article featuring one of our top thought leaders in the February 2017 issue of Healthcare Purchasing News. Tim Lantz, Senior Vice President, GM, Sentry Analytics & Product Design, shared his insights as part of a panel on how supply chain professionals can use clinical data analytics to help doctors succeed.

Main article Making meaningful use of data for physicians

Sidebar discussion Analysis vs. analytics: A defining moment?

 

Sentry analytics solutions featured in HFMA’s Healthcare Cost Containment publication

Three Rivers Health is a 60-bed, multi-specialty, community-owned, non-profit regional medical center in southwest Michigan that also offers home care, hospice and a comprehensive wellness facility. Five years ago, Three Rivers was operating in the red and lacked visibility and insights to properly diagnose and address its challenges. Like many rural health systems, the organization had come to rely upon manual processes and extensive Excel spreadsheets in an attempt to understand the costs of delivering care and managing labor. These challenges led the Three Rivers leadership team to reconsider its strategy and look for a better technology solution with the ability to identify issues while there was still time to intervene. Read how Sentry’s analytics solutions were instrumental in helping turn Three Rivers’ finances around in the February issue of HFMA’s Healthcare Cost Containment.